Moreover, the intricate connection between the evolutionarily ancient p53 family and metabolic enzymes is consistent with the notion that the mutations in oncogenes and tumor suppressors are clonally selected during tumorigenesis, at least in part, due to their benefit in conferring metabolic adaptation4,43. Here, TP53 is linked to neoplasm.